Zevra Therapeutics, Inc. (ZVRA)
NASDAQ·Healthcare·Biotechnology
$12.60
-0.28%
Mkt Cap $747.81M
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (13 analysts)
$25.50
Range $25.00 – $26.00
Implied Upside
+102.5%
Consensus $25.50 vs current $12.60
NASDAQ·Healthcare·Biotechnology
$12.60
-0.28%
Mkt Cap $747.81M
Buy
7
Hold
0
Sell
0
Price Target (13 analysts)
$25.50
Range $25.00 – $26.00
+102.5%
Consensus $25.50 vs current $12.60